Palobiofarma SL
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Therapeutic Effect of PBF-680 in Patients With COPD (NCT05262218) | Palobiofarma SL | 2021-12-20 |
| Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers. (NCT03798236) | Palobiofarma SL | 2018-12-10 |
| PBF-1129 in Patients With NSCLC (NCT03274479) | Palobiofarma SL | 2018-10-01 |
| Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients (NCT03773952) | Palobiofarma SL | 2018-07-01 |
| Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients (NCT03774290) | Palobiofarma SL | 2018-06-01 |
| Study of PBF-999 in Solid Tumour Advanced Cancer (NCT03786484) | Palobiofarma SL | 2017-10-01 |
Track Palobiofarma SL automatically
Every clearance here is in the API, with alerts when new ones post.